Skip to main content
Home
Home
  • Register here
  • Sign In
  • Home
  • News Feed
  • Therapeutic areas
    • Cardio-Metabolic
      • Heart Failures
      • Dyslipidemia
    • Dermatology
      • Psoriasis (PsO)
    • Ophthalmology
      • Ophthalmology
    • Respiratory
      • BLOCK IgE; UNLOCK LIFE in 3 indications
      • IgE-Related Chronic Diseases
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Melanoma
      • Oncology Publication
    • Hematology
      • CML
      • ITP
      • MPN
      • SAA
    • Transplant
      • Transplant
    • Neurology
      • Dementia
    • Rare Disease
      • Spinal Muscular Atrophy (SMA)
  • Exclusive event

Popular Search

  • heart
  • heart failure
  • medical
  • medical information/c
  • dme

Recent News

IgE-Related Chronic Diseases TISTOK
LIPID Management and CVD Forum 2024
PEAK 2024 (SAA & MPN)
Search
  1. VDO test

https://www.kaltura.com/index.php/extwidget/preview/partner_id/2076321/uiconf_id/46737343/entry_id/1_5xrpv9k9/embed/iframe?

×

Medical Information Request

×

Ask Speakers

Latest Content

Oncology

LET hER SMILE CDK Playlist EP2

LET hER SMILE CDK Playlist EP2 //--> 17 min 18 sec LET hER SMILE CDK Playlist 2/4: Gain invaluable insights from five leading experts on treating aggressive tumor burdens in ER+/HER2- advanced breast cancer

Home Show More

Print
Transplant

Transplant Publication

The Burden of Gastrointestinal Complaints in Kidney Transplant Recipients Using Tacrolimus

Tacrolimus (TAC) combined with mycophenolate mofetil (MMF) is the immunosuppressive regimen in the majority of solid organ transplant recipients.Show More

Print
SMA

SMA Publication

Apr-2021

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial

John W Day, Richard S Finkel, et al.

CheckoutShow More
Print
SMA

SMA Webinar

Upcoming Event

Previous Next Show More

Print

Spinal Muscular Atrophy (SMA)

Print
Oncology

LET hER SMILE CDK Playlist

LET hER SMILE CDK Playlist EP1 //--> 13 min 58 sec LET hER SMILE CDK Playlist 1/4: Gain invaluable insights from five leading experts on treating aggressive tumor burdens in ER+/HER2- advanced breast cancer

Home Show More

Print
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
 of  39
Sitemap
©2025 Novartis Pharma
  • Terms of use
  • Privacy
The site is intended for HCP local audiences